Sparsentan:a non-immunosuppressive drug treating IgA nephropathyJI Ya-chun, JIA Hui-xia, QI Jun-sheng225-230
Comprehensive efficacy evaluation system for stable coronary angina diseaseXU Jia-xin, DAI Xin-yue, ZHAO Yang, YU Bin-yang, GAO Rui231-235
Core technology topic identification and technology evolution trend analysis of non-small cell lung cancerYANG Feng, YUAN Hong-mei236-243
A β-lactamase inhibitor combination:sulbactam/durlobactamYANG Jun, LIU Fang, YU Ming-jie, CHENG Lin, CHEN Yong-chuan244-248
Research on the optimization direction of drug review and approval based on continuous encouragement of innovationZHANG Xiao-yong, GAO Li-ping, NIU Jia-wei, LV Xin-huan, CHEN Sheng-xian, ZHANG Xiang-lin, WU Zhi-ang256-263
Research progress on new drugs derived from effective components of single herb of traditional Chinese medicineXIAO Wei-ting, ZENG Qiong-li, ZHANG Heng, HAN Yue, ZHOU Hua-rong, XIAO Xiao, WANG Xiong-long, LI Shun-xiang, OUYANG Wen264-269
Clinical research progress on Rh-endostatin in the treatment of nonsmall-cell lung cancerWANG Pei, ZHU Jian-bo270-274
Clinical observation of 341 cases of COVID-19 infection treated with a Tibetan medicine combination regimen in plateau regionsDUO Jie-tai, GESANG Yun-dan, ZHANG Qiong-wen, PINGCUO Duo-ji, WANG Bao, SUOLANG Ren-qing, SANG Dan, SHEN Yan-ru, LI Yan-jun, REN Qing-jia, DANSONG Zha-ba, BIANBA Ci-ren, TANG Jian-yuan, CHEN Wei-wu275-281
Clinical effect of compound Huangbai liquid on preventing postoperative complications of mandibular mesio-impacted third molarCHEN Lun-qiu, LI Zhi-cong, LIANG Huan-huan, LAN Li-yun, OUYANG Ke-xiong, PIAO Zheng-guo, CHEN Hao282-285